An In Vitro and In Vivo Cholinesterase Inhibitory Activity of Pistacia khinjuk and Allium sativum Essential Oils
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
rodegenerative disease, has deleterious effects on the brain that consequently causes memory loss and language impairment. This study was intended to investigate the neuroprotective activity of the two essential oils (EOs) from Iranian Pistacia khinjuk (PK) leaves and Allium sativum (AS) cloves against β-Amyloid 25–35 (Aβ25-35) induced elevation of cholinesterase enzymes in AD. Methods: The EOs of PK (PKEO) and AS (ASEO) were prepared and analyzed in terms of extraction yield, phenolic content, and cholinergic markers in vitro. Moreover, both were administered orally to adult male Wistar rats at concentrations of 1, 2, and 3%. The inhibitory potential of PKEO and ASEO was compared with Donepezil (0.75 mg/kg) against the high activities of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzymes. Results: PKEO reached an inhibition rate of 83.6% and 81.4% against AChE and BChE, respectively. ASEO had lower anti-cholinesterase activity (65.4% and 31.5% for the inhibition AChE and BChE). PKEO was found to have more phenolic content than ASEO. A significantly positive correlation was observed between the total phenolics and anti-cholinesterase potential. In rats, both EOs decreased the enzyme activity in a concentration-dependent manner. As compared with Donepezil, the significant difference in the AChE and BChE inhibition occurred as rats were treated with PKEO 3% (p < 0.05). Conclusion: It could be concluded that PKEO and ASEO are potent inhibitors of AChE and BChE in rats that hold promise to be used for the treatment of AD.
Abstract
rodegenerative disease, has deleterious effects on the brain that consequently causes memory loss and language impairment. This study was intended to investigate the neuroprotective activity of the two essential oils (EOs) from Iranian Pistacia khinjuk (PK) leaves and Allium sativum (AS) cloves against β-Amyloid 25–35 (Aβ25-35) induced elevation of cholinesterase enzymes in AD. Methods: The EOs of PK (PKEO) and AS (ASEO) were prepared and analyzed in terms of extraction yield, phenolic content, and cholinergic markers in vitro. Moreover, both were administered orally to adult male Wistar rats at concentrations of 1, 2, and 3%. The inhibitory potential of PKEO and ASEO was compared with Donepezil (0.75 mg/kg) against the high activities of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzymes. Results: PKEO reached an inhibition rate of 83.6% and 81.4% against AChE and BChE, respectively. ASEO had lower anti-cholinesterase activity (65.4% and 31.5% for the inhibition AChE and BChE). PKEO was found to have more phenolic content than ASEO. A significantly positive correlation was observed between the total phenolics and anti-cholinesterase potential. In rats, both EOs decreased the enzyme activity in a concentration-dependent manner. As compared with Donepezil, the significant difference in the AChE and BChE inhibition occurred as rats were treated with PKEO 3% (p < 0.05). Conclusion: It could be concluded that PKEO and ASEO are potent inhibitors of AChE and BChE in rats that hold promise to be used for the treatment of AD.
참고문헌 (49)
- Sosa-Ortiz AL, "Epidemiology of dementias and Alzheimer’s disease", Archives of medical research, 43(8), pp.600~608 (2012)
- Bartus RT, "The cholinergic hypothesis of geriatric memory dysfunction", Science, 217(4558), pp.408~414 (1982)
- Du X, "Alzheimer’s disease hypothesis and related therapies", Translational Neurodegeneration, 7, pp.2~ (2018)
- Houghton PJ, "Natural products and derivatives affecting neurotransmission relevant to Alzheimer's and Parkinson's disease", Neurosignals, 14(1-2), pp.6~22 (2005)
- Heinrich M, "Galanthamine from snowdrop- the development of a modern drug against Alzheimer's disease from local Caucasian knowledge", Journal of ethnopharmacology, 92(2-3), pp.147~162 (2004)
- Grutzendler J, "Cholinesterase inhibitors for Alzheimer's disease", Drugs, 61(1), pp.41~52 (2001)
- Kumar A, "A review on Alzheimer's disease pathophysiology and its management : an update", Pharmacol Rep, 67(2), pp.195~203 (2015)
- Essa MM, "Neuroprotective effect of natural products against Alzheimer’s disease", Neurochemical research, 37(9), pp.1829~1842 (2012)
- Saeedeh Ebrahimpour, "Boswellic Acid Improves Cognitive Function in a Rat Model Through Its Antioxidant Activity - Neuroprotective effect of Boswellic acid -", Journal of Pharmacopuncture, 20(1), pp.10~17 (2017), 대한약침학회[DOI]
- Edris AE, "Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents : a review", Phytotherapy research : PTR, 21(4), pp.308~323 (2007)
- Ayaz M, "Comparative chemical profiling, cholinesterase inhibitions and anti-radicals properties of essential oils from Polygonum hydropiper L : A Preliminary anti-Alzheimer’s study", Lipids in Health and Disease, 14, pp.141~ (2015)
- Okello E, "In vitro inhibition of human acetyl-and butyryl-cholinesterase by Narcissus poeticus L. (Amaryllidaceae) flower absolute", Int J Essent Oil Ther, 2, pp.105~110 (2008)
- Nishiyama N, "Ameliorative effect of S-allylcysteine, a major thioallyl constituent in aged garlic extract, on learning deficits in senescence-accelerated mice", The Journal of nutrition, 131(3), pp.1093S~1095S (2001)
- Tasnim S, "Allium sativum L. improves visual memory and attention in healthy human volunteers", Evidence- Based Complementary and Alternative Medicine, pp.2015~ (2015)
- Chauhan NB, "Anti-amyloidogenic effect of Allium sativum in Alzheimer's transgenic model Tg2576", Journal of herbal pharmacotherapy, 3(1), pp.95~107 (2003)
- Ncir M, "In vitro and in vivo studies of Allium sativum extract against deltamethrin-induced oxidative stress in rats brain and kidney", Arch Physiol Biochem, 124(3), pp.207~217 (2018)
- Azimi M, "The Use of Pistacia khinjuk Essential Oil to Modulate Shelf-Life and Organoleptic Traits of Mechanically Deboned Chicken Meat", J Food Process Preserv (2016)
- Asha H, "A Review : Natural Compounds as Anti-Alzheimer´s Disease Agents", Current Nutrition & Food Science, 13(4), pp.247~254 (2017)
- Hacıbekiroğlu Iı, "In vitro biological activities and fatty acid profiles of Pistacia terebinthus fruits and Pistacia khinjuk seeds", Natural product research, 29(5), pp.444~446 (2015)
- Rauf A, "Pistagremic acid as a broad spectrum natural inhibitor from Pistacia integerrima Stewart", Natural product research, 31(4), pp.367~368 (2017)
- Aktumsek A, "Antioxidant potentials and anticholinesterase activities of methanolic and aqueous extracts of three endemic Centaurea L. species", Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 55, pp.290~296 (2013)
- Kumar A, "Centella asiatica attenuates D-galactose-induced cognitive impairment, oxidative and mitochondrial dysfunction in mice", International journal of Alzheimer’s disease, 2011, pp.1~9 (2011)
- Borek C, "Antioxidant and cancer", Sci Med, 4, pp.51~62 (1997)
- Gutteridge JM, "Free radicals in disease processes : a compilation of cause and consequence", Free radical research communications, 19(3), pp.141~158 (1993)[DOI]
- Moriguchi T, "Anti-ageing effect of aged garlic extract in the inbred brain atrophy mouse model", Clinical and experimental pharmacology & physiology, 24(3-4), pp.235~242 (1997)
- Nishiyama N, "Beneficial effects of aged garlic extract on learning and memory impairment in the senescence-accelerated mouse", Experimental gerontology, 32(1-2), pp.149~160 (1997)
- Ghasemi Pirbalouti A, "Chemical composition of essential oil of Pistacia khinjuk stocks grown in Bakhtiari Zagross Mountains, Iran", Electronic Journal of Biology, 7(4), pp.67~69 (2011)
- Taran M, "Antimicrobial activity of the leaves of Pistacia khinjuk", Journal of Medicinal Plants, 1(33), pp.81~85 (2010)
- Inglis F., "The tolerability and safety of cholinesterase inhibitors in the treatment of dementia", International journal of clinical practice Supplement, 127, pp.45~63 (2002)
- Jann MW, "Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors", Clinical pharmacokinetics, 41(10), pp.719~739 (2002)
- Abolghasemi A, "Composition of Pistacia khinjuk (Anacardiaceae) Leaf Essential Oil and its Insecticidal Activity on Common Pistachio Psyllid, Agonoscena pistaciae (Hem., Psylloidea)", Journal of Essential Oil Bearing Plants, 21(3), pp.796~802 (2018)
- Taran M, "Antimicrobial activity of the leaves of Pistacia khinjuk", J Medicin Plant, 1(33), pp.81~85 (2010)
- De Pooter H, "Essential oils from the leaves of three Pistacia species grown in Egypt", Flavour and Fragrance journal, 6(3), pp.229~232 (1991)
- Rahnama M, "Antibacterial effects of Myristica fragrans, Zataria multiflora Boiss, Syzygium aromaticum, and Zingiber officinale Rosci essential oils, alone and in combination with nisin on Listeria monocytogenes", Comp Clin Pathol, 21(6), pp.1313~1316 (2012)
- Khadri S, "Antibacterial activity evaluation of Allium sativum essential oil compared to different Pseudomonas aeruginosa strains in Eastern Algeria", Scientific Study & Research, 11(4), pp.421~428 (2010)
- Lawrence R, "Antioxidant activity of garlic essential oil (Allium sativum) grown in north Indian plains", Asian Pac J Trop Biomed, 1(Suppl 1), pp.S51~S54 (2011)
- Mnayer D, "Chemical composition, antibacterial and antioxidant activities of six essentials oils from the Alliaceae family", Molecules(Basel, Switzerland), 19(12), pp.20034~20053 (2014)
- Casella S, "The role of diallyl sulfides and dipropyl sulfides in the in vitro antimicrobial activity of the essential oil of garlic, Allium sativum L., and leek, Allium porrum L", Phytotherapy Research, 27(3), pp.380~383 (2013)
- Corzo-Martínez M, "Biological properties of onions and garlic", Trends in food science & technology, 18(12), pp.609~625 (2007)
- Sultana B, "Antioxidant activity of phenolic components present in barks of Azadirachta indica, Terminalia arjuna, Acacia nilotica, and Eugenia jambolana Lam. trees", Food Chemistry, 104(3), pp.1106~1114 (2007)
- Borek C, "Garlic reduces dementia and heart-disease risk", J Nutr, 136(3), pp.810S~812S (2006)
- Mikaili P, "Therapeutic uses and pharmacological properties of garlic, shallot, and their biologically active compounds", Iranian journal of basic medical sciences, 16(10), pp.1031~1048 (2013)
- Cortes N, "Neuroprotective activity and acetylcholinesterase inhibition of five Amaryllidaceae species : A comparative study", Life sciences, 122, pp.42~50 (2015)
- Heinrich M, "Galanthamine from snowdrop—the development of a modern drug against Alzheimer’s disease from local Caucasian knowledge", Journal of ethnopharmacology, 92(2-3), pp.147~162 (2004)
- Kumar S, "Dual inhibition of acetylcholinesterase and butyrylcholinesterase enzymes by allicin", Indian journal of pharmacology, 47(4), pp.444~446 (2015)
- Elufioye TO, "Anticholinesterase constituents from the leaves of Spondias mombin L. (Anacardiaceae)", Biologics : Targets & Therapy, 11, pp.107~114 (2017)
- Moyo M, "Phenolic composition, antioxidant and acetylcholinesterase inhibitory activities of Sclerocarya birrea and Harpephyllum caffrum(Anacardiaceae)extracts", Food Chemistry, 123(1), pp.69~76 (2010)
- Ali Reza ASM, "In vitro antioxidant and cholinesterase inhibitory activities of Elatostema papillosum leaves and correlation with their phytochemical profiles : a study relevant to the treatment of Alzheimer’s disease", BMC complementary and alternative medicine, 18, pp.123~ (2018)
- Bone K, "Principles and practice of phytotherapy: modern herbal medicine" (2013), Elsevier Health Sciences